<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914444/" ref="ordinalpos=108&amp;ncbi_uid=5823752&amp;link_uid=PMC3914444" image-link="/pmc/articles/PMC3914444/figure/F2/" class="imagepopup">Figure 2.  From: Customizing the Therapeutic Response of <span class="highlight" style="background-color:">Signaling</span> Networks to Promote Antitumor Responses by Drug Combinations. </a></div><br /><div class="p4l_captionBody"><b>Scheme of PI3K/PTEN/AKT signaling network activated by heterodimerization of HER2/HER3 receptors induced by heregulin (HRG) and inhibited by pertuzumab, 2C4</b>. Decomposition of the signaling network to upstream pathway (receptor signaling pathway) and down-stream pathway (PI3K/PTEN/AKT network) is shown.</div></div>